FDA Inspection 826054 - Regenerative Biologics, Inc. - April 08, 2013

Record Details

This FDA Inspection record concerns Regenerative Biologics, Inc., with an inspection on April 8, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Regenerative Biologics, Inc.
Inspection Date: April 8, 2013
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · db2217ed-4cef-4d3d-bff5-5934809df35a

Violation Codes2

21 CFR 1271.180(a)21 CFR 1271.260(e)

Full citation text and observation details available on the Dashboard.